Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Meiragtx Holdings Plc (MGTX)

$23.85 0.87 (3.79%)

16:39 EDT MGTX Stock Quote Delayed 15 Minutes

Volume:

Previous Close $23.85

Market Cap 648.34M

PE Ratio -

EPS -

Volume (Avg. Vol.) 194,300

Day's Range 22.67 - 24.00

52-Week Range 7.98 - 24.76

Dividend & Yield N/A (N/A)

MGTX Stock Predictions, Articles, and Meiragtx Holdings Plc News

From the Web

Best & Worst Performing Small Cap Stocks for June 25, 2019

From StockNews.com Jun 25, 2019

GEMP – GEMP leads the way today as the best performing small cap stock, closing up 29.03%.

Why This Vertex Buyout Could Signal A Buying Spree In Gene Editing

From Investor's Business Daily Jun 7, 2019

Vertex is betting on gene-editing treatments with the takover of biotech company Exonics Therapeutics and a deeper collaboration with Crispr Therapeutics.

3 Promising Gene Therapy Stocks

From Talk Markets May 26, 2019

Investor interest in gene therapy companies has been on the rise. Here is a look at 3 promising small cap gene therapy companies.

Why This Biotech Stock Looks Prime For A Johnson & Johnson Buyout

From Investor's Business Daily May 17, 2019

Dow Jones component Johnson & Johnson could buy out biotech stock MeiraGTx for its efforts in gene therapy, an analyst suggested Friday.

Chardan Capital Believes Meiragtx Holdings Plc (MGTX) Still Has Room to Grow

From Smarter Analyst May 17, 2019

Chardan Capital analyst Gbola Amusa reiterated a Buy rating on Meiragtx Holdings Plc (MGTX) today and set a price target of $40. The company's shares

The Daily Biotech Pulse: Axovant Doses First Patient In Gene Therapy Trial, Agile Resubmits NDA, ADMA Prices Offering

From Benzinga May 17, 2019

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on May 16) Adverum Biotechnologies...

Navellier Ratings

Powered by Portfolio Grader

Total Grade

A

Strong Buy

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!